共 50 条
- [2] First-Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area-Under-the-Curve Target Attainment in Critically Ill Patients [J]. PHARMACOTHERAPY, 2020, 40 (12): : 1210 - 1218
- [6] External Validation of Obese/Critically Ill Vancomycin Population Pharmacokinetic Models in Critically Ill Patients Who Are Obese [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (03): : 353 - 361
- [7] Relationship between nephrotoxicity and area under the concentration-time curve of vancomycin in critically ill patients: a multicenter retrospective study [J]. MICROBIOLOGY SPECTRUM, 2024, 12 (07):
- [8] Review and Validation of Bayesian Dose-Optimizing Software and Equations for Calculation of the Vancomycin Area Under the Curve in Critically Ill Patients [J]. PHARMACOTHERAPY, 2018, 38 (12): : 1174 - 1183
- [9] Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancer [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (01):